Savellano Dagmar Högemann, Köstler Herbert, Baus Stefan, Mössinger Meike, Gratz Klaus Friedrich, Weimann Arved, Galanski Michael
Abteilung für Diagnostische Radiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
Invest Radiol. 2004 May;39(5):305-12. doi: 10.1097/01.rli.0000120372.55482.eb.
Sequential contrast changes of mangafodipir trisodium (Mn-DPDP)-enhanced magnetic resonance imaging (MRI) were evaluated in the differentiation of focal nodular hyperplasias (FNH) and hepatocellular carcinomas (HCC).
Patients with FNH (n = 16) or HCC (n = 12) underwent MRI: T2-weighted fast spin echo before and T1-weighted gradient echo before and 1, 4, 14, and 22 hours after 5 micromol/kg Mn-DPDP. Homogeneity of enhancement and delineation of fibrous scars of FNHs were assessed qualitatively. Lesion-to-liver contrast changes of FNHs and HCCs were compared quantitatively (Mann-Whitney U).
Mn-DPDP improved detection of characteristic scars of FNHs from 50% before to 90% after contrast agent. Apart from fibrous tissue enhancement of FNHs was mostly homogeneous (90%). Time-dependent contrast changes were up to 20 times higher (after 4 hours) for FNHs than HCCs (P < 0.0001).
Mn-DPDP-enhanced MRI helps to delineate characteristic morphologic features of FNHs and can provide quantitative data differentiating FNH and HCC.
评估锰福地匹三钠(Mn-DPDP)增强磁共振成像(MRI)的序列对比变化,以鉴别局灶性结节性增生(FNH)和肝细胞癌(HCC)。
16例FNH患者和12例HCC患者接受MRI检查:在静脉注射5 μmol/kg Mn-DPDP前及注射后1、4、14和22小时分别进行T2加权快速自旋回波序列及T1加权梯度回波序列扫描。定性评估FNH的强化均匀性及纤维瘢痕显示情况。定量比较FNH和HCC的病灶-肝脏对比变化(Mann-Whitney U检验)。
Mn-DPDP使FNH特征性瘢痕的检出率从造影剂注射前的50%提高到注射后的90%。除纤维组织强化外,FNH的强化大多均匀(90%)。FNH的时间依赖性对比变化比HCC高20倍(4小时后)(P < 0.0001)。
Mn-DPDP增强MRI有助于勾勒FNH的特征性形态学特征,并可提供鉴别FNH与HCC的定量数据。